The future of medicine came into sharp focus this past September as leaders from across the healthcare world converged in Boston.
From 15–17 September, the World Medical Innovation Forum 2025 brought together top minds from academia, industry, and government at the Encore Boston Harbor.
Hosted by Mass General Brigham and Bank of America, the forum served as a nexus for discovery, collaboration, and investment, setting the agenda for the next era of healthcare.
AI in the Clinic: From theory to bedside
This year, discussions went beyond theory, diving into how AI is being deployed in real-world clinical settings. Sessions like “AI at the Bedside” and “AI Diagnostics” showcased how AI is being integrated into workflows to improve patient care and streamline operations.
“The integration of AI into clinical workflows isn’t just a tech upgrade—it’s a pathway to better patient care.”
-Dr. David Brown, President of Academic Medical Centers, Mass General Brigham
Speakers such as Microsoft’s Global Chief Medical Officer, Dr. David Rhew, and CEOs from leading AI firms PathAI and Viz.ai highlighted the collaborative push between tech and healthcare. They also emphasized risks, including cybersecurity and privacy, underscoring that innovation must go hand-in-hand with caution.
Oncology’s next frontier
Cancer care is rapidly becoming more personalised and patient-centric. Sessions explored the latest therapies—from bispecific antibodies to innovative drug combinations—aimed at targeting cancer at the molecular level.
Thought leaders like Dr. Keith Flaherty and Dr. David Ryan of Mass General Brigham, alongside industry pioneers such as Parabilis CEO Dr. Mathai Mammen, discussed strategies to outsmart cancer, emphasizing precision and personalization.
Gene Editing, Xenotransplantation, and Precision Medicine
What was once science fiction is now edging closer to the bedside. Sessions on gene editing and xenotransplantation showed how these technologies are becoming tangible treatment options. With experts like Dr. David Liu of the Broad Institute, the focus was on translating lab breakthroughs into real-world therapies.
“These technologies are moving rapidly from lab discovery to clinical reality.”
-Dr. David Liu, Broad Institute
Policy, regulation, and global dynamics
True medical innovation requires more than just science; it needs policy and market alignment. Attendees heard from Gov. Maura Healey, Sen. Susan Collins, and Dr. Robert Califf from Duke University about the intersection of science, policy, and global markets.
“From strengthening our health agencies and supporting rural hospitals, to ensuring access to Medicaid and advancing medical breakthroughs, our work must focus on protecting patients, empowering researchers, and maintaining America’s global leadership in health and science.”
–Senator Susan Collins (R-Maine)
Sessions on Medicare reform with CMS advisor Chris Klomp and China’s biotech boom highlighted the need for breakthroughs to navigate regulatory and economic realities to scale effectively.
Venture and investment insights
Healthcare’s financial landscape is evolving. Major hospitals are launching venture arms to fund and commercialize internal innovations. While investors from BofA Securities, Foresite Capital, and Sanofi Ventures shared insights on emerging trends and opportunities.
“Hospitals launching their own VC arms signals a new era—internal innovation is now a competitive advantage.”
-Dr. David Reese, EVP & Chief Medical Officer, Amgen
The future of medicine is as much about smart funding as it is about science.
Executive and c-suite participation
Fireside chats offered a rare glimpse into the minds of healthcare’s top executives. Visionaries like Merck CMO Dr. Eliav Barr, Johnson & Johnson’s Dr. John Reed, Biogen CEO Chris Viehbacher, and Eli Lilly CMO Dr. David Hyman shared their strategies for steering large organizations through rapid innovation.
Medtech leaders, including CEOs from GE HealthCare and Siemens Healthineers, discussed operational and technological advancements, while Bank of America CEO Brian Moynihan offered perspectives on the macroeconomic environment shaping healthcare investment.
“The future of healthcare is being shaped by the convergence of science, care delivery, and federal policy.”
-Anne Klibanski, MD, President and CEO, Mass General Brigham
Key sessions: Highlights from the stage
Beyond opioids: Smarter pain relief
Moderated by pain psychologist Rob Edwards, panelists explored alternatives to opioids. Vertex’s Paul Nigillescu stressed the urgent need for better treatments for severe pain, while Lilit Garibbean highlighted the quest for therapies that are “long-lasting and durable.”
Disability tech: Building a universal future
Moderator Sabrina Paganoni led a discussion on inclusive technology.
MIT’s Hugh Herr envisioned a future where bionic devices are so “integrated into human physiology that it becomes human.” Gina Rinehart noted a pivotal shift, with innovators with disabilities “building the technology themselves.”
The core principle, as Lily Collison put it, is that “universal design is so important” for creating a truly accessible world.
Saving sight: A new era for eye care
Dr.Rishi Singh moderated a session on ophthalmology’s revolution. Panelists highlighted a move toward “personalized medicine,” with AI and genomics tailoring glaucoma care.
Astellas’ Dr. Erin Kimmerle pointed to gene therapy Luxturna as a “proof of principle,” while Dr. Peter Baronoff predicted retinal regeneration via transplantation to be “achievable within 5 to 10 years.”
The silent pandemic: Fighting antimicrobial resistance
Experts sounded the alarm on antimicrobial resistance (AMR). Mayo Clinic’s Dr. Robin Patel called it a “huge… global challenge.” The discussion highlighted a critical roadblock: the broken economics of antibiotic development.
Kevin Krauss of Aryath noted the stark reality that no antibiotic has “made back the money that was invested into it,” underscoring the need for new models.
The silver tsunami: Preparing for an aging world
Facing an aging global population, experts outlined solutions. McKinsey’s Anu Madgavkar outlined the root cause: globally “falling fertility rates.” To manage the strain, Mass General Brigham’s O’Neil Britton discussed expanding home-based care with technology.
Rippl Care’s Kris Engskov warned that dementia care infrastructure is vastly underprepared.
“We are waist-deep in it right now, and we are still vastly underprepared.”
Kraft Prize for AI-Driven Innovation in Community Health
The Kraft Prize for Excellence and Innovation in Community Health was awarded to Thrive Link for its groundbreaking work. The organization’s AI-driven solution uses simple phone calls to help people enroll in essential health and social services. This helps in effectively overcoming the digital divide.
“Leveraging AI and technology is imperative to create meaningful impact in community health.”
-Robert Kraft
The bottom line
The World Medical Innovation Forum 2025 made it clear that the future of medicine is no longer on the horizon; it is here.
From AI and gene therapy to inclusive tech and policy solutions, the forum highlighted a shift from theory to patient-centered, actionable innovation.
The conversations in Boston have set the agenda, and now the work to implement it is underway.
-By Alkama Sohail and the AHT Team
